Product NDC: | 0093-2055 |
Proprietary Name: | Tolterodine Tartrate |
Non Proprietary Name: | TOLTERODINE TARTRATE |
Active Ingredient(s): | 2 mg/1 & nbsp; TOLTERODINE TARTRATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-2055 |
Labeler Name: | TEVA Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020771 |
Marketing Category: | NDA |
Start Marketing Date: | 20120511 |
Package NDC: | 0093-2055-05 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0093-2055-05) |
NDC Code | 0093-2055-05 |
Proprietary Name | Tolterodine Tartrate |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0093-2055-05) |
Product NDC | 0093-2055 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TOLTERODINE TARTRATE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120511 |
Marketing Category Name | NDA |
Labeler Name | TEVA Pharmaceuticals USA Inc |
Substance Name | TOLTERODINE TARTRATE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |